Azel 80 Capsule

Introduction

Azel is a prescription medication that contains the active ingredient Enzalutamide. It is available in capsule form and is primarily used for the treatment of prostate cancer.

Uses

Azel is prescribed to patients with prostate cancer that has spread to other parts of the body. It works by blocking the actions of male hormones in the prostate, which can slow down the growth of cancer cells and potentially shrink the tumor.

Dosage and Administration

The dosage of Azel will vary depending on the individual patient and their specific condition. Follow the instructions provided by your healthcare professional. Typically, the recommended dose is one capsule taken orally once daily, with or without food. Swallow the capsule whole with a glass of water. Do not crush, chew, or open the capsule.

Mechanism of Action

Enzalutamide, the active ingredient in Azel, belongs to a class of medications known as androgen receptor inhibitors. It works by blocking the binding of male hormones, such as testosterone, to the androgen receptors in the prostate cancer cells. By doing so, it helps to inhibit the growth and spread of cancer cells.

Side Effects

Common side effects may include fatigue, decreased appetite, constipation, diarrhea, and headache. Note that not all patients will experience these side effects, and they may vary in severity.

Serious side effects are rare but can occur. If you experience any of the following symptoms, seek medical attention immediately: severe allergic reactions (such as rash, itching, swelling, dizziness, or difficulty breathing), chest pain, shortness of breath, seizures, or signs of liver problems (such as yellowing of the skin or eyes, dark urine, or persistent nausea).

Drug Interactions

inform your healthcare professional about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. Some medications may interact with Azel and potentially increase the risk of side effects or affect its effectiveness. Common drug interactions may include certain anticoagulants, seizure medications, and medications that affect liver enzymes.

Precautions

Before taking Azel, discuss your medical history and any existing conditions with your healthcare professional. This medication may not be suitable for everyone. It is contraindicated in women who are pregnant or may become pregnant, as it can cause harm to the developing fetus.

Additionally, Azel should be used with caution in patients with liver problems or a history of seizures. Follow your healthcare professional’s advice and undergo regular check-ups to monitor your condition while taking this medication.

Storage

Azel should be stored at room temperature, away from moisture and heat. Keep the medication in its original packaging and out of reach of children. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Follow your healthcare professional’s instructions regarding the dosage and administration of Azel.
• If you miss a dose, take it as soon as you remember, unless it is close to the time for your next dose. Do not double the dose to make up for a missed one.
• attend all scheduled medical appointments and laboratory tests to monitor your condition and the effectiveness of the medication.
• Inform your healthcare professional if you experience any new or worsening symptoms while taking Azel.
• Do not share your medication with others, as it is prescribed specifically for your condition.
• If you have any questions or concerns about Azel, consult your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Enzalutamide (Drugs.com) [Accessed 11 Jun. 2024] (online) Available at:
• enzalutamide capsule (RX) [Accessed 18 Jun. 2024] (online) Available at:
• Enzalutamide (MedlinePlus) [Accessed 19 Jun. 2024] (online) Available at:
• Armstrong AJ, Szmulewitz RZ, Petrylak DP, Holzbeierlein J, Villers A, Azad A, Alcaraz A, Alekseev B, Iguchi T, Shore ND, Rosbrook B, Sugg J, Baron B, Chen L, Stenzl A. ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer. J Clin Oncol. 2019 Nov 10;37(32):2974-2986. doi: 10.1200/JCO.19.00799. Epub 2019 Jul 22. [Accessed 29 Jun. 2024] Available at: